TCL Archive FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one. September 16, 2005
TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals September 20, 2013
